Position in PFE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$852,143
-$785,959 QoQ
Shares Held
35,388
-39.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#1,421
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hanson & Doremus Investment Management holds $28,323,234 across 13 Drug Manufacturers - General names. PFE ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
56,094 | $7,208,079 | |
| 2 | LLY |
ELI LILLY & Co
|
3,655 | $4,383,917 | |
| 3 | ABBV |
AbbVie Inc.
|
16,581 | $4,172,442 | |
| 4 | JNJ |
Johnson & Johnson
|
16,303 | $4,140,472 | |
| 5 | AMGN |
Amgen Inc
|
10,917 | $3,953,264 | |
| 6 | AZN |
Astrazeneca PLC
|
5,916 | $1,121,791 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
18,157 | $1,046,206 | |
| 8 | PFE |
Pfizer Inc
This page
|
35,388 | $852,143 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $852,143 | 35,388 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,638,102 | 58,337 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,217,926 | 129,234 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $3,424,129 | 134,385 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $3,565,461 | 147,090 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $3,912,217 | 154,389 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $3,690,880 | 139,121 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $3,985,414 | 137,713 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $3,865,856 | 138,165 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,660,225 | 131,900 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $3,350,666 | 116,383 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $3,013,826 | 90,860 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $3,366,893 | 91,791 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $3,790,768 | 92,911 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $5,619,900 | 109,678 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $4,277,277 | 97,744 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $5,160,213 | 98,421 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $5,287,063 | 102,126 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $6,031,603 | 102,144 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $4,418,675 | 102,736 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $4,449,868 | 113,633 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $4,392,959 | 121,252 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $4,508,930 | 122,492 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $4,170,326 | 113,633 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $3,781,726 | 115,649 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $4,364,125 | 133,705 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||